Today marks the 50th anniversary of the introduction of the heel prick test (or newborn blood spot screening) in the Netherlands. This test involves the collection of a few drops of blood from newborn babies and screening the blood for serious...

Since 1 October, the metabolic disorder adrenoleukodystrophy (ALD) has been added to the Dutch newborn blood spot screening. From now on, the blood of newborn boys will also be tested for this disorder. ALD in boys can be treated if it is detected in time.

From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.

As of 1 January 2017, the disorders alpha and beta thalassaemia will be added to the neonatal blood spot (‘heel prick’) screening programme.

On 26 October 2015, heel prick screening started for all newborns on St Eustatius and Saba.